Index- P/E- EPS (ttm)-2.15 Insider Own7.40% Shs Outstand10.22M Perf Week-9.54%
Market Cap37.45M Forward P/E- EPS next Y-0.91 Insider Trans1.21% Shs Float9.09M Perf Month-33.60%
Income-21.30M PEG- EPS next Q-0.25 Inst Own54.70% Short Float / Ratio0.51% / 4.21 Perf Quarter-39.75%
Sales36.30M P/S1.03 EPS this Y51.10% Inst Trans-0.50% Short Interest0.05M Perf Half Y-50.96%
Book/sh4.16 P/B0.80 EPS next Y51.30% ROA-35.50% Target Price14.00 Perf Year-52.02%
Cash/sh1.71 P/C1.94 EPS next 5Y- ROE-44.40% 52W Range3.46 - 8.80 Perf YTD-44.57%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-62.27% Beta-
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin52.60% 52W Low-4.05% ATR0.32
Employees110 Current Ratio3.30 Sales Q/Q-7.20% Oper. Margin-59.50% RSI (14)26.52 Volatility8.10% 8.40%
OptionableYes Debt/Eq0.00 EPS Q/Q40.10% Profit Margin-58.70% Rel Volume1.58 Prev Close3.59
ShortableYes LT Debt/Eq0.00 EarningsNov 09 BMO Payout- Avg Volume11.10K Price3.32
Recom1.00 SMA20-21.50% SMA50-33.66% SMA200-46.14% Volume17,194 Change-7.52%
Feb-24-21Initiated SVB Leerink Outperform $20
Nov-22-22 08:00AM
Nov-09-22 07:00AM
Nov-02-22 08:00AM
Sep-08-22 07:00AM
Aug-16-22 07:00AM
07:00AM Loading…
Aug-08-22 07:00AM
Aug-01-22 08:00AM
Jun-13-22 07:00AM
Jun-09-22 07:30AM
May-09-22 07:00AM
May-02-22 08:00AM
Apr-21-22 09:08AM
Mar-03-22 07:00AM
Mar-01-22 07:00AM
Feb-28-22 04:01PM
02:01AM Loading…
Feb-23-22 02:01AM
Feb-10-22 08:00AM
Jan-04-22 08:00AM
Dec-31-21 07:53AM
Nov-16-21 08:00AM
Nov-12-21 07:00AM
Nov-08-21 07:00AM
Nov-01-21 08:00AM
Oct-02-21 10:32AM
Sep-02-21 08:00AM
Aug-16-21 08:00AM
Aug-05-21 07:00AM
Jul-29-21 08:00AM
Jul-15-21 08:00AM
May-24-21 08:00AM
07:00AM Loading…
May-05-21 07:00AM
Apr-28-21 08:00AM
Mar-10-21 07:00AM
Mar-03-21 04:05PM
Feb-16-21 01:28PM
Feb-08-21 08:00AM
Feb-01-21 07:00AM
Jan-03-21 03:58AM
Nov-23-20 08:00AM
Nov-11-20 04:01PM
Nov-09-20 04:01PM
Nov-02-20 08:00AM
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winer Gary MDirectorNov 23Buy3.609763,51439,552Nov 23 04:46 PM
Winer Gary MDirectorNov 22Buy3.601,5245,48638,576Nov 23 04:46 PM
Winer Gary MDirectorNov 17Buy4.101,5006,15037,052Nov 17 06:09 PM
Winer Gary MDirectorNov 16Buy4.251,0004,25035,552Nov 17 06:09 PM
Winer Gary MDirectorAug 18Buy6.002,00012,00034,552Aug 22 04:57 PM
Winer Gary MDirectorAug 17Buy6.053,00018,15032,552Aug 22 04:57 PM